CD40 and neoplasm: We have shown that three i.t. injections of IL-2 modified tumor blood vessels (32) and recruited CD8+ T cells into the tumor bed whilst three i.t. injections of IL-2 combined with an agonist anti-CD40 antibody recruited a massive and simultaneous infiltrate of neutrophils and T cells (7).